Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × INDIV × Bevacizumab × Clear all

Phase

Status

Sponsor Class

OTHER 513 INDUSTRY 299 NIH 117 NETWORK 26 UNKNOWN 1 OTHER_GOV 1 INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

Proflavine 3 Microbial Collagenase 2 sargramostim 1 pembrolizumab 1 pegfilgrastim 1 macimorelin 1 keyhole-limpet hemocyanin 1 Sodium Chloride 1 Sirolimus 1 Peptides 1 Monatide (IMS 3015) 1 Ipilimumab 1 Gemcitabine 1 Everolimus 1 Bimatoprost 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00775073 2012-04-30

Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001

Treiber, Gerhard

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡